Stocks and Investing Stocks and Investing
Fri, October 4, 2019
Thu, October 3, 2019

Joel Beatty Initiated (ARWR) at Buy and Held Target at $39 on, Oct 3rd, 2019


Published on 2024-10-26 16:36:53 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Baird, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy and Held Target at $39 on, Oct 3rd, 2019.

Joel has made no other calls on ARWR in the last 4 months.



There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 1 agrees with Joel's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elemer Piros of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Friday, June 28th, 2019


This is the rating of the analyst that currently disagrees with Joel


  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $46 on, Monday, August 19th, 2019

Contributing Sources